CY2011004I1 - Χιμαιρικοι λοιμωδεις κλωνοι dna του κυκλοϊου των χοιρων και χρησεις εξ αυτων - Google Patents

Χιμαιρικοι λοιμωδεις κλωνοι dna του κυκλοϊου των χοιρων και χρησεις εξ αυτων

Info

Publication number: CY2011004I1
Authority: CY; Cyprus
Prior art keywords: chimeral; circular dna; dna clones; pig circular; infectious
Prior art date: 2001-12-12

Application number

CY2011004C

Other languages

English (en)

Other versions

CY2011004I2 (el

Original Assignee

Virginia Tech Intellectual Properties, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-12

Filing date

2011-05-06

Publication date

2014-04-09

2011-05-06 Application filed by Virginia Tech Intellectual Properties, Inc. filed Critical Virginia Tech Intellectual Properties, Inc.

2014-04-09 Publication of CY2011004I1 publication Critical patent/CY2011004I1/el

2015-10-07 Publication of CY2011004I2 publication Critical patent/CY2011004I2/el

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10061—Methods of inactivation or attenuation

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Biochemistry (AREA)
General Chemical & Material Sciences (AREA)
Microbiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biophysics (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

CY2011004C 2001-12-12 2011-05-06 Χιμαιρικοι λοιμωδεις κλωνοι dna του κυκλοϊου των χοιρων και χρησεις εξ αυτων CY2011004I2 (el)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US34077501P	2001-12-12	2001-12-12
US42484002P	2002-11-08	2002-11-08
US10/314,512 US7276353B2 (en)	2001-12-12	2002-12-09	Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
PCT/US2002/039646 WO2003049703A2 (en)	2001-12-12	2002-12-11	Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof

Publications (2)

Publication Number	Publication Date
CY2011004I1 true CY2011004I1 (el)	2014-04-09
CY2011004I2 CY2011004I2 (el)	2015-10-07

Family

ID=27405726

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
CY20111100127T CY1111167T1 (el)	2001-12-12	2011-02-03	Χιμαιρικοι λοιμωδεις κλωνοι dna του κυκλοϊου των χοιρων και χρησεις εξ αυτων
CY2011004C CY2011004I2 (el)	2001-12-12	2011-05-06	Χιμαιρικοι λοιμωδεις κλωνοι dna του κυκλοϊου των χοιρων και χρησεις εξ αυτων
CY181101151T CY1121112T1 (el)	2001-12-12	2018-11-05	Χιμαιρικοι λοιμωδεις κλωνοι dna του κυκλοϊου των χοιρων και χρησεις εξ αυτων

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
CY20111100127T CY1111167T1 (el)	2001-12-12	2011-02-03	Χιμαιρικοι λοιμωδεις κλωνοι dna του κυκλοϊου των χοιρων και χρησεις εξ αυτων

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
CY181101151T CY1121112T1 (el)	2001-12-12	2018-11-05	Χιμαιρικοι λοιμωδεις κλωνοι dna του κυκλοϊου των χοιρων και χρησεις εξ αυτων

Country Status (30)

Country	Link
US (1)	US7276353B2 (el)
EP (5)	EP2263689B1 (el)
JP (1)	JP4623964B2 (el)
KR (1)	KR101014544B1 (el)
CN (2)	CN103536911B (el)
AT (1)	ATE487490T1 (el)
AU (3)	AU2002362147C1 (el)
BE (1)	BE2011C008I2 (el)
BR (1)	BRPI0214919B1 (el)
CA (2)	CA2469599C (el)
CO (1)	CO5590938A2 (el)
CY (3)	CY1111167T1 (el)
DE (2)	DE60238278D1 (el)
DK (3)	DK1487483T3 (el)
ES (3)	ES2694505T3 (el)
FR (1)	FR11C0014I2 (el)
HR (3)	HRP20140003B1 (el)
HU (5)	HU228584B1 (el)
LT (1)	LT2264050T (el)
LU (1)	LU91814I2 (el)
ME (1)	ME00126B (el)
MX (1)	MXPA04005364A (el)
NL (1)	NL300480I2 (el)
NZ (2)	NZ567688A (el)
PL (3)	PL215058B1 (el)
PT (3)	PT2263689E (el)
RS (1)	RS51288B (el)
SI (3)	SI2263689T1 (el)
TW (1)	TWI314580B (el)
WO (1)	WO2003049703A2 (el)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2772047B1 (fr) *	1997-12-05	2004-04-09	Ct Nat D Etudes Veterinaires E	Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
US7279166B2 (en) *	2001-12-12	2007-10-09	Virginia Tech Intellectual Properties, Inc.	Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
CN1749397B (zh) *	2004-08-18	2010-12-08	金宁一	共表达猪圆环病毒及口蹄疫病毒的二联重组活载体疫苗
US7833707B2 (en)	2004-12-30	2010-11-16	Boehringer Ingelheim Vetmedica, Inc.	Methods of overexpression and recovery of porcine circovirus type 2 ORF2
HUE046045T2 (hu)	2004-12-30	2020-01-28	Boehringer Ingelheim Animal Health Usa Inc	PCV2 immunogén készítmények és eljárások ilyen készítmények elõállítására
US7700285B1 (en)	2005-12-29	2010-04-20	Boehringer Ingelheim Vetmedica, Inc.	PCV2 immunogenic compositions and methods of producing such compositions
UA95602C2 (ru)	2004-12-30	2011-08-25	Берингер Ингельхейм Ветмедика, Инк.	Иммуногенная композиция цвс2 и способы приготовления такой композиции
US8834891B2 (en)	2005-03-14	2014-09-16	Boehringer Ingelheim Vetmedica, Inc.	Immunogenic compositions comprising Lawsonia intracellularis
CN1328373C (zh) *	2005-04-07	2007-07-25	南京农业大学	猪ⅱ型圆环病毒重组腺病毒
BRPI0611581B1 (pt) *	2005-06-24	2021-08-03	Intervet International B.V.	Flavivírus quimérico inativado, composição imunogênica, e, vacina
RU2389506C2 (ru)	2005-09-09	2010-05-20	Интервет Интернэшнл Б.В.	Вакцина против рсv-2
RU2488407C2 (ru)	2005-12-29	2013-07-27	Берингер Ингельхайм Ветмедика, Инк.	Поливалентные иммуногенные композиции pcv2 и способы получения таких композиций
DK2371383T3 (en)	2005-12-29	2015-11-30	Boehringer Ingelheim Vetmed	Use of a PCV2 immunogenic composition for reduction of clinical symptoms in pigs
JP4625485B2 (ja) *	2006-09-29	2011-02-02	財団法人大阪産業振興機構	高病原性トリインフルエンザウイルスに対するモノクローナル抗体
EP2099927A4 (en) *	2006-11-22	2010-05-05	Boehringer Ingelheim Vetmed	Methods of reducing porcine circovirus-associated disease outbreaks
US20100129397A1 (en)	2006-12-11	2010-05-27	Boehringer Ingelheim Vetmedica, Inc.	Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
DK2481420T3 (da)	2006-12-15	2019-05-06	Boehringer Ingelheim Animal Health Usa Inc	Enkeltdosis-anti-PCV2-svinevaccine
EP1941903A1 (en)	2007-01-03	2008-07-09	Boehringer Ingelheim Vetmedica Gmbh	Prophylaxis and treatment of PRDC
EP1958644A1 (en) *	2007-02-13	2008-08-20	Boehringer Ingelheim Vetmedica Gmbh	Prevention and treatment of sub-clinical pcvd
CN101730742A (zh) *	2007-05-30	2010-06-09	惠氏有限责任公司	表达猪类病毒基因的浣熊痘病毒
US20090017064A1 (en) *	2007-07-10	2009-01-15	Wyeth	Methods and Compositions for Immunizing Pigs Against Porcine Circovirus
US7829274B2 (en) *	2007-09-04	2010-11-09	Boehringer Ingelheim Vetmedica, Inc.	Reduction of concomitant infections in pigs by the use of PCV2 antigen
AU2008324780A1 (en) *	2007-11-06	2009-05-14	Pah W Llc	Mycoplasma hyopneumoniae avirulent -adjuvanted live vaccine
AU2008343172B2 (en) *	2007-12-21	2015-02-19	Zoetis Services Llc	Methods and compositions for immunizing pigs against porcine circovirus
AU2008347235A1 (en) *	2007-12-31	2009-07-16	Boehringer Ingelheim Vetmedica, Inc.	PCV2 ORF2 virus like particle with foreign amino acid insertion
EP2242511A4 (en) *	2008-01-23	2012-10-24	Boehringer Ingelheim Vetmed	IMMUNOGENIC COMPOSITIONS OF MYCOPLASMA HYOPNEUMONIAE PCV2, AND METHODS FOR PRODUCING SUCH COMPOSITIONS
WO2009103037A1 (en) *	2008-02-15	2009-08-20	Boehringer Ingelheim Vetmedica, Inc.	Methods and compositions for reducing the impact of enteric diseases
JP2011519273A (ja) *	2008-04-16	2011-07-07	ヴァージニアテックインテレクチュアルプロパティーズ，インコーポレーテッド	キメラブタサーコウイルスＰＣＶ２Ｇｅｎ−１Ｒｅｐおよびその使用
TWI627281B (zh)	2009-09-02	2018-06-21	百靈佳殷格翰家畜藥品公司	降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
SI2547770T1 (sl)	2010-03-16	2020-07-31	Virginia Tech Intellectual Properties, Inc.	Vakcina atenuiranega živega himernega prašičjega virusa
TWI508974B (zh)	2010-12-22	2015-11-21	Sbc Virbac Ltd	豬第二型環狀病毒(Porcine Circovirus Type 2)、含彼之免疫組合物、檢測套組及其應用
EP2660356A4 (en)	2010-12-28	2014-07-09	Jx Nippon Oil & Energy Corp	DEVICE FOR HYDROGENATING ORGANIC COMPOUNDS AND HYDROGENATION METHODS
HUP1100470A2 (en) *	2011-08-30	2013-03-28	Mezoegazdasagi Biotechnologiai Kutatokoezpont	Nanoparticle-based veterinary vaccine
UA113192C2 (xx)	2011-12-06	2016-12-26		Імуногенна композиція проти цирковірусу свиней типу 2 (pcv2)
UA114504C2 (uk)	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
UA114503C2 (uk)	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv та mycoplasma hyopneumoniae
US9120859B2 (en)	2012-04-04	2015-09-01	Zoetis Services Llc	Mycoplasma hyopneumoniae vaccine
KR102217387B1 (ko) *	2013-03-11	2021-02-19	주식회사 중앙백신연구소	재조합 효모 전세포(yeast whole cell)을 이용한 돼지 써코바이러스(PCV2) 서브유닛 백신과 그의 제조 방법
KR20160046879A (ko)	2013-09-25	2016-04-29	조에티스 서비시즈 엘엘씨	Pcv2b 분지형 백신 조성물 및 사용 방법
CN105658660A (zh)	2013-10-02	2016-06-08	勃林格殷格翰动物保健公司	Pcv2 orf2蛋白变体和由其组成的病毒样颗粒
CN103602759B (zh) *	2013-11-22	2015-09-23	福建省农业科学院畜牧兽医研究所	一种区别鸭圆环病毒和鹅圆环病毒的pcr-rflp方法
CA2931137C (en)	2013-12-03	2023-03-14	Intervet International B.V.	Vaccine against porcine circo virus type 2
WO2017187277A2 (en) *	2016-03-07	2017-11-02	Virginia Tech Intellectual Properties, Inc.	Chimeric porcine circovirus type 2 (pcv2) vaccines
CN106497892A (zh) *	2016-09-07	2017-03-15	扬州大学	带KT3标签的重组病毒rPCV2‑KT3的构建方法
WO2019191005A1 (en)	2018-03-26	2019-10-03	Boehringer Ingelheim Animal Health USA Inc.	Method of producing an immunogenic composition
CN112898435B (zh) *	2021-01-14	2023-03-31	山西农业大学	一种可溶性融合蛋白DT390-Cap及其制备方法与应用
CN121013728A (zh)	2023-05-03	2025-11-25	勃林格殷格翰动物保健有限公司	一种可用于猪自我施用的免疫原性组合物
AU2024265654A1 (en)	2023-05-03	2025-12-04	Boehringer Ingelheim Vetmedica Gmbh	Method for inducing an immune response
US20250332242A1 (en)	2024-04-30	2025-10-30	Zoetis Services Llc	Porcine endogenous retrovirus (perv)-free porcine circovirus type 2d-based vaccines and methods of use
US20250332243A1 (en)	2024-04-30	2025-10-30	Zoetis Services Llc	Methods of manufacturing porcine endogenous retrovirus (perv) free animal health vaccines

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2769321B1 (fr)	1997-10-03	2001-10-26	Merial Sas	Nouveaux circovirus porcins, vaccins et reactifs de diagnostics
US6517843B1 (en)	1999-08-31	2003-02-11	Merial	Reduction of porcine circovirus-2 viral load with inactivated PCV-2
FR2781159B1 (fr)	1998-07-06	2000-10-06	Merial Sas	Vaccin circovirus et parvovirus porcin
FR2769322B1 (fr)	1997-10-03	2002-03-08	Merial Sas	Nouveaux circovirus porcins, vaccins et reactifs de diagnostic
UA78180C2 (uk)	1997-10-03	2007-03-15	Меріаль	Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
US6391314B1 (en)	1997-10-03	2002-05-21	Merial	Porcine circoviruses vaccines diagnostic reagents
FR2772047B1 (fr)	1997-12-05	2004-04-09	Ct Nat D Etudes Veterinaires E	Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
ES2289796T3 (es) *	1997-12-11	2008-02-01	University Of Saskatchewan	Virus del sindrome del desmedro post-destete procedente de cerdos.
EP1064024A4 (en)	1998-03-13	2005-04-06	Univ Georgia Res Found	VACCINES AGAINST CIRCOVIRUS INFECTIONS
US6943152B1 (en)	1999-06-10	2005-09-13	Merial	DNA vaccine-PCV
US6497883B1 (en)	1999-06-10	2002-12-24	Merial	Porcine circovirus recombinant poxvirus vaccine
WO2001083737A2 (en)	2000-05-03	2001-11-08	University Of Guelph	Porcine adenovirus type 5 vector and vaccine
WO2001089559A2 (en)	2000-05-24	2001-11-29	Merial	Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine
MXPA02012352A (es)	2000-06-15	2004-09-06	Purdue Research Foundation	Vacuna para temblores congenitos en cerdos.
DE10044648A1 (de)	2000-09-08	2002-03-21	Aventis Behring Gmbh	Verfahren zur Vermehrung oder zur Entfernung von Cirocoviren aus biologischem Material
SK287969B6 (sk)	2001-03-27	2012-08-06	University Of Saskatchewan	Method to culture circovirus
AUPR567401A0 (en)	2001-06-14	2001-07-12	University Of Melbourne, The	Circovirus vaccines

2002
- 2002-12-09 US US10/314,512 patent/US7276353B2/en not_active Expired - Lifetime
- 2002-12-11 HU HU0501000A patent/HU228584B1/hu active Protection Beyond IP Right Term
- 2002-12-11 NZ NZ567688A patent/NZ567688A/en not_active IP Right Cessation
- 2002-12-11 CN CN201210306454.2A patent/CN103536911B/zh not_active Expired - Lifetime
- 2002-12-11 ES ES10184702.8T patent/ES2694505T3/es not_active Expired - Lifetime
- 2002-12-11 BR BRPI0214919A patent/BRPI0214919B1/pt active IP Right Grant
- 2002-12-11 ME MEP-2008-177A patent/ME00126B/me unknown
- 2002-12-11 EP EP10184612.9A patent/EP2263689B1/en not_active Expired - Lifetime
- 2002-12-11 HR HRP20140003AA patent/HRP20140003B1/hr not_active IP Right Cessation
- 2002-12-11 HR HRP20040626AA patent/HRP20040626B9/hr not_active IP Right Cessation
- 2002-12-11 SI SI200231053T patent/SI2263689T1/sl unknown
- 2002-12-11 SI SI200230932T patent/SI1487483T1/sl unknown
- 2002-12-11 HU HU1300097A patent/HU230576B1/hu unknown
- 2002-12-11 MX MXPA04005364A patent/MXPA04005364A/es active IP Right Grant
- 2002-12-11 HU HU1600373A patent/HU231018B1/hu unknown
- 2002-12-11 AU AU2002362147A patent/AU2002362147C1/en not_active Expired
- 2002-12-11 EP EP18175133.0A patent/EP3388515A1/en active Pending
- 2002-12-11 PT PT101846129T patent/PT2263689E/pt unknown
- 2002-12-11 DE DE60238278T patent/DE60238278D1/de not_active Expired - Lifetime
- 2002-12-11 PL PL395509A patent/PL215058B1/pl unknown
- 2002-12-11 SI SI200231091T patent/SI2264050T1/sl unknown
- 2002-12-11 EP EP02797280A patent/EP1487483B1/en not_active Expired - Lifetime
- 2002-12-11 DK DK02797280.1T patent/DK1487483T3/da active
- 2002-12-11 DK DK10184702.8T patent/DK2264050T3/en active
- 2002-12-11 HR HRP20140002AA patent/HRP20140002B1/hr not_active IP Right Cessation
- 2002-12-11 ES ES02797280T patent/ES2355814T3/es not_active Expired - Lifetime
- 2002-12-11 PL PL374382A patent/PL214803B1/pl not_active IP Right Cessation
- 2002-12-11 CA CA2469599A patent/CA2469599C/en not_active Expired - Lifetime
- 2002-12-11 AT AT02797280T patent/ATE487490T1/de active
- 2002-12-11 JP JP2003550754A patent/JP4623964B2/ja not_active Expired - Lifetime
- 2002-12-11 DE DE201112100001 patent/DE122011100001I1/de active Pending
- 2002-12-11 ES ES10184612.9T patent/ES2529726T3/es not_active Expired - Lifetime
- 2002-12-11 EP EP10184771A patent/EP2263690A3/en not_active Withdrawn
- 2002-12-11 CN CN02828049.0A patent/CN1620310B/zh not_active Expired - Lifetime
- 2002-12-11 CA CA2784260A patent/CA2784260C/en not_active Expired - Lifetime
- 2002-12-11 KR KR1020047009126A patent/KR101014544B1/ko not_active Expired - Lifetime
- 2002-12-11 EP EP10184702.8A patent/EP2264050B1/en not_active Expired - Lifetime
- 2002-12-11 RS YUP-517/04A patent/RS51288B/sr unknown
- 2002-12-11 PT PT10184702T patent/PT2264050T/pt unknown
- 2002-12-11 HU HU1800263A patent/HU231162B1/hu active Protection Beyond IP Right Term
- 2002-12-11 PT PT02797280T patent/PT1487483E/pt unknown
- 2002-12-11 LT LTEP10184702.8T patent/LT2264050T/lt unknown
- 2002-12-11 NZ NZ533256A patent/NZ533256A/en not_active IP Right Cessation
- 2002-12-11 DK DK10184612.9T patent/DK2263689T3/en active
- 2002-12-11 WO PCT/US2002/039646 patent/WO2003049703A2/en not_active Ceased
- 2002-12-11 PL PL395510A patent/PL395510A1/pl not_active Application Discontinuation
- 2002-12-12 TW TW091135955A patent/TWI314580B/zh not_active IP Right Cessation
2004
- 2004-06-10 CO CO04054666A patent/CO5590938A2/es unknown
2008
- 2008-05-27 AU AU2008202333A patent/AU2008202333B2/en not_active Expired
2011
- 2011-02-03 CY CY20111100127T patent/CY1111167T1/el unknown
- 2011-02-25 AU AU2011200843A patent/AU2011200843B2/en not_active Expired
- 2011-04-29 BE BE2011C008C patent/BE2011C008I2/fr unknown
- 2011-05-02 LU LU91814C patent/LU91814I2/fr unknown
- 2011-05-03 FR FR11C0014C patent/FR11C0014I2/fr active Active
- 2011-05-06 CY CY2011004C patent/CY2011004I2/el unknown
- 2011-05-06 NL NL300480C patent/NL300480I2/nl unknown
2018
- 2018-11-05 CY CY181101151T patent/CY1121112T1/el unknown
2021
- 2021-09-14 HU HUS2100036C patent/HUS2100036I1/hu unknown

Also Published As

Publication number	Publication date
AU2008202333B2 (en)	2010-11-25
PL214803B1 (pl)	2013-09-30
BR0214919A (pt)	2006-05-30
JP2005511075A (ja)	2005-04-28
EP2264050A2 (en)	2010-12-22
ES2355814T3 (es)	2011-03-31
WO2003049703A8 (en)	2005-12-01
CA2784260C (en)	2016-05-17
HRP20040626B1 (hr)	2016-08-26
EP3388515A1 (en)	2018-10-17
CA2784260A1 (en)	2003-06-19
CA2469599A1 (en)	2003-06-19
WO2003049703A3 (en)	2004-09-30
WO2003049703A2 (en)	2003-06-19
MXPA04005364A (es)	2004-09-27
DK2264050T3 (en)	2018-12-03
EP2264050A3 (en)	2011-04-20
EP2264050B1 (en)	2018-08-08
CO5590938A2 (es)	2005-12-30
PL215058B1 (pl)	2013-10-31
US20030170270A1 (en)	2003-09-11
HRP20140002B1 (hr)	2020-10-16
ES2694505T3 (es)	2018-12-21
CY1111167T1 (el)	2014-04-09
PT2264050T (pt)	2018-11-21
AU2008202333A1 (en)	2008-06-19
NZ567688A (en)	2009-09-25
PL395510A1 (pl)	2011-12-19
CN103536911A (zh)	2014-01-29
HUS2100036I1 (hu)	2021-09-28
ES2529726T3 (es)	2015-02-25
HRP20140003A2 (hr)	2014-11-07
PT1487483E (pt)	2011-02-10
ATE487490T1 (de)	2010-11-15
HRP20140003B1 (hr)	2020-10-16
SI2263689T1 (sl)	2015-03-31
EP2263689A3 (en)	2011-04-20
ME00126B (me)	2010-10-10
HU230576B1 (hu)	2017-01-30
NZ533256A (en)	2008-06-30
AU2011200843A1 (en)	2011-03-17
BRPI0214919B1 (pt)	2015-09-15
DE60238278D1 (de)	2010-12-23
PT2263689E (pt)	2015-02-13
LU91814I2 (fr)	2011-07-04
EP1487483A2 (en)	2004-12-22
FR11C0014I1 (el)	2011-06-17
CY2011004I2 (el)	2015-10-07
AU2002362147A1 (en)	2003-06-23
EP1487483B1 (en)	2010-11-10
DK2263689T3 (en)	2015-02-02
EP2263689A2 (en)	2010-12-22
AU2002362147B2 (en)	2008-03-13
HK1151988A1 (en)	2012-02-17
EP2263689B1 (en)	2014-11-12
CA2469599C (en)	2012-10-23
HU231018B1 (hu)	2019-11-28
AU2011200843B2 (en)	2012-01-19
HU228584B1 (en)	2013-04-29
CN1620310B (zh)	2014-11-26
DE122011100001I1 (de)	2011-09-08
AU2002362147C1 (en)	2012-05-17
EP1487483A4 (en)	2006-02-15
HUP1300097A2 (en)	2007-12-28
CN103536911B (zh)	2019-09-13
HU231162B1 (hu)	2021-05-28
NL300480I2 (el)	2016-11-01
HRP20040626A2 (en)	2006-03-31
CY1121112T1 (el)	2019-12-11
TW200307042A (en)	2003-12-01
SI1487483T1 (sl)	2011-03-31
DK1487483T3 (da)	2011-02-21
MEP17708A (bs)	2010-06-10
KR101014544B1 (ko)	2011-02-16
TWI314580B (en)	2009-09-11
RS51704A (sr)	2006-10-27
EP2263690A2 (en)	2010-12-22
LT2264050T (lt)	2018-11-26
CN1620310A (zh)	2005-05-25
HRP20140002A2 (hr)	2014-11-07
US7276353B2 (en)	2007-10-02
BE2011C008I2 (el)	2022-02-02
RS51288B (sr)	2010-12-31
FR11C0014I2 (fr)	2022-03-11
HRP20040626B9 (hr)	2016-09-23
EP2263690A3 (en)	2011-06-08
HUP0501000A2 (en)	2007-12-28
JP4623964B2 (ja)	2011-02-02
PL374382A1 (en)	2005-10-17
PL395509A1 (pl)	2011-12-19
SI2264050T1 (sl)	2018-12-31
KR20040086243A (ko)	2004-10-08

Publication	Publication Date	Title
CY2011004I2 (el)	2015-10-07	Χιμαιρικοι λοιμωδεις κλωνοι dna του κυκλοϊου των χοιρων και χρησεις εξ αυτων
DE60238478D1 (de)	2011-01-13	Eren
DE60212600D1 (de)	2006-08-03	Audiocodierung und decodierung
DE60229216D1 (de)	2008-11-20	Mram architektur und system
DE50112013D1 (de)	2007-03-22	Deodorantien und antiperspirantien
DE60206625D1 (de)	2005-11-17	Haarkonditionierungsmittel
EP1298180A4 (en)	2005-03-09	HYDROPHOBIC AND LIPOPHOBE COMPOSITION
DE60223344D1 (de)	2007-12-20	Silicoaluminophosphat-molekularsieb
EP1453968A4 (en)	2006-08-09	BETA-GLUCOSIDASE BGL4 AND NUCLEIC ACIDS ENCODING IT
DE60216254D1 (de)	2007-01-04	Acrylkautschukzusammensetzung und vulkanisat
DE60204686D1 (de)	2005-07-21	3-arylsubstituierte zyklopentadienyl-metal-komplexe und polymerisationsverfahren
NO20035121D0 (no)	2003-11-17	Ny anvendelse
NO20030239D0 (no)	2003-01-17	Modifisert virus
NO20022092D0 (no)	2002-05-02	Orienterings- og lokaliseringssystem
DE60223044D1 (de)	2007-11-29	Granulatförmiges herbizid
DE60203475D1 (de)	2005-05-04	Drosselklappe und Drossel
DE60227607D1 (de)	2008-08-28	Spielsystem und Spielprogramm
NO20033919D0 (no)	2003-09-04	Ny anvendelse
FI20010432A0 (fi)	2001-03-05	Puhallin
DE60205008D1 (de)	2005-08-18	Kettelverfahren und -vorrichtung
DE60219418D1 (de)	2007-05-24	Silanylphenole und -naphthole
FR2821760B1 (fr)	2003-06-20	Le cochonnet aimante
KR100522448B1 (ko)	2005-11-15	Hiv 유사입자 및 그 용도
NO20023822L (no)	2003-03-07	Luftfordeler
FR2822657B1 (fr)	2003-07-04	Poignee de manutention